The University of Texas MD Anderson Cancer Center and The University of Texas at Austin have launched a joint initiative, the ...

She entered a clinical trial at Duke University's Preston Robert Tisch Brain Tumor ... with only a 10% chance of survival ...

In recognition of their significant achievements to advance cancer care and research, Lauren Byers, M.D., and Paul Scheet, Ph ...

Surgery may not be the best next course of treatment for patients with early-stage breast cancer who had a complete response ...

Houston-based University of Texas MD Anderson Cancer Center and the University of Texas at Austin have launched a partnership in support of research projects designed to improve cancer prevention, ...

The University of Texas MD Anderson Cancer Center today announced that Jeffrey E. Lee, M.D., an internationally regarded ...

according to new data from researchers at The University of Texas MD Anderson Cancer Center. Five-year results from the Phase II trial, published today in JAMA Oncology, revealed that breast ...

Erzsébet Merényi, a statistics research professor at Rice University, and co-investigators at The University of Texas MD Anderson Cancer Center Pratip Bhattacharya, professor of cancer systems imaging ...

Dr. Debu Tripathy explains how ctDNA is used to in breast cancer detection and how it can also indicate the presence of MRD.

HPV driven cancers, including HPV+ HNSCC, are characterized by defects in the DDR pathway, making them potentially susceptible to WEE1 inhibition. HPV+ cancers are those where the underlying cause is ...

Current guidelines lack consensus and rely on lower-quality evidence, according to the author of new research.